LARVOL
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
LARVOL
May 23, 2024, 14:08 |
Blog
Tune in to the LARVOL ONCOLOGY DATA WEBINAR
Larvol posted on X/Twitter: "As we are close to ASCO 2024, don't miss this opportunity…
Apr 11, 2024, 12:38 |
Blog
Key drugs at AACR 2024 by LARVOL
LARVOL shared on X/Twitter: "Exploring the key drugs at AACR 2024? Dive into the abstracts, including…
Apr 1, 2024, 19:03 |
Blog
Top Influencers in GU Ocology by LARVOL
LARVOL shared on their X/Twitter page: "Delving into GU Oncology, we’re thrilled to spotlight the…
Mar 30, 2024, 14:25 |
Blog
Stephen V Liu Leads Top Influencers at ELCC 2024 by LARVOL
LARVOL/X recently shared a list of top influencers and their impact from ELCC 2024, where…
Mar 5, 2024, 16:04 |
Blog
Pashtoon Kasi leads the peer ranked "Top 10 Voices in GI Oncology on X" by LARVOL
LARVOL/X recently shared the results of peer survey on "Top Voices in GI Oncology on…
Mar 5, 2024, 14:22 |
Blog
GI Oncology voices that stand out - as selected by peer survey - LARVOL
Quoting LARVOL on LinkedIn: "Diving into the discussions on X (formerly Twitter) around GI Oncology,…
All:
6
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube